IntroductionTreatment of brain tumors in dogs can be associated with significant morbidity and reliable prognostic factors are lacking. Dynamic contrast-enhanced computed tomography (DCECT) can be used to assess tumor perfusion. The objectives of this study were to assess perfusion parameters and change in size of suspected brain tumors before and during radiotherapy (RT) depending on their location and find a potential correlation with survival.MethodsSeventeen client-owned dogs with suspected brain tumors were prospectively recruited. All dogs had a baseline DCECT to assess mass size, blood volume (BV), blood flow (BF), and transit time (TT). Twelve dogs had a repeat DCECT after 12 Gy of megavoltage RT. Survival times were calculated.Resu...
Radiotherapy with or without surgery is a common choice for brain tumors in dogs. Although numerous...
Post-treatment outcome in canine glial tumours is described with a broad range of survival times bet...
The overall survival of patients with malignant gliomas remains dismal despite multimodality treatme...
BackgroundStereotactic radiosurgery (SRS) and stereotactic radiotherapy (SRT) are highly conformal, ...
Tumours show large variations in response to radiotherapy, both across tumour types and within indiv...
Single photon emission computed tomography (SPECT) of the brain using perfusion tracers allows estim...
Background: Local progression of intracranial tumors can be the consequence of insufficient radiatio...
OBJECTIVE To determine values of perfusion parameters determined via MRI in the brains of healthy do...
Seizures are a common presenting sign in dogs with brain tumors. To investigate the effect of radiot...
Background: Radiotherapy (RT) is an effective treatment for dogs presented with neurologic signs c...
Brain gliomas are common tumours diagnosed in dogs. However, limited information is available on the...
Dynamic liver CT scanning is used to observe the hemodynamics of hepatic tumor-like lesions by takin...
BACKGROUND: Use of strongly hypofractionated radiation treatments in dogs with intracranial neoplasi...
BACKGROUND: Radiotherapy (RT) is an effective treatment for dogs presented with neurologic signs cau...
Tumor volume is controversially discussed as a prognostic factor in dogs treated with radiation ther...
Radiotherapy with or without surgery is a common choice for brain tumors in dogs. Although numerous...
Post-treatment outcome in canine glial tumours is described with a broad range of survival times bet...
The overall survival of patients with malignant gliomas remains dismal despite multimodality treatme...
BackgroundStereotactic radiosurgery (SRS) and stereotactic radiotherapy (SRT) are highly conformal, ...
Tumours show large variations in response to radiotherapy, both across tumour types and within indiv...
Single photon emission computed tomography (SPECT) of the brain using perfusion tracers allows estim...
Background: Local progression of intracranial tumors can be the consequence of insufficient radiatio...
OBJECTIVE To determine values of perfusion parameters determined via MRI in the brains of healthy do...
Seizures are a common presenting sign in dogs with brain tumors. To investigate the effect of radiot...
Background: Radiotherapy (RT) is an effective treatment for dogs presented with neurologic signs c...
Brain gliomas are common tumours diagnosed in dogs. However, limited information is available on the...
Dynamic liver CT scanning is used to observe the hemodynamics of hepatic tumor-like lesions by takin...
BACKGROUND: Use of strongly hypofractionated radiation treatments in dogs with intracranial neoplasi...
BACKGROUND: Radiotherapy (RT) is an effective treatment for dogs presented with neurologic signs cau...
Tumor volume is controversially discussed as a prognostic factor in dogs treated with radiation ther...
Radiotherapy with or without surgery is a common choice for brain tumors in dogs. Although numerous...
Post-treatment outcome in canine glial tumours is described with a broad range of survival times bet...
The overall survival of patients with malignant gliomas remains dismal despite multimodality treatme...